Linda Rubinstein Email Address

Partner

PaxVax is a leading independent vaccine company devoted to developing and commercializing specialty vaccines that protect against existing and emerging infectious diseases.

I have over 25 years of operational, financial and capital markets experience in life sciences and software, with particular expertise in biotechnology, life science tools and diagnostics. As CFO, I have overseen finance at R&D- and commercial-stage enterprises, consummated financing and M&A transactions, and contributed to operations and strategy at private and public companies. As an investment banker, I completed over 30 transactions, raising over $5 billion in capital for companies ranging from emerging start-ups to Fortune 500 companies. I am a partner of FLG Partners, Northern California's leading CFO services and board advisory firm. While at FLG, I have served as interim and full-time CFO for companies such as:* ArmaGen, a biotech company delivering protein drugs across the blood brain barrier to address orphan and neurodegenerative diseases* True North, a biotech company developing novel therapies that selectively target the Complement pathway of the immune system* PaxVax, a specialty vaccine company, where I executed financings totaling up to $62 million, was instrumental in the acquisition of vaccine assets from J&J / Crucell and designed the company's international tax structure* iPierian, a biotechnology company developing novel therapies for neurodegenerative disease; sold to BMS in 2014* Ingenuity Systems, a SaaS company serving life science research and diagnostics, sold to QIAGEN for $105 million in April 2013Prior to joining FLG, I was the sole principal of RDJ Advisors, providing interim CFO and other consulting services to life science and software companies. Earlier, I was the CFO of Solexa, a publicly traded firm manufacturing and selling genetic analysis instrumentation, sold to Illumina in 2007; VP Finance at ChemoCentryx, a biotech company; and SVP of Lehman Brothers’ Healthcare Investment Banking Group. I was formerly on the board of Sensorin, an analytical instrument company.Contact me at linda@flgpartners.com.